Post-influenza aspergillosis, do not underestimate influenza B

References

• van de SandtCEBodewesRRimmelzwaanGFde VriesRDInfluenza B viruses: not to be discountedFuture Microbiol20151091447146526357957
   PubMed Web of Science ®Google Scholar
• PaddockCDLiuLDenisonAMMyocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infectionJ Infect Dis2012205689590522291193
   PubMed Web of Science ®Google Scholar
• McCullersJAHaydenFGFatal influenza B infections: time to reexamine influenza research prioritiesJ Infect Dis201215205687087222291194
   PubMed Web of Science ®Google Scholar
• LatABhadeliaNMikoBFuruyaEYThompsonGR3rdInvasive aspergillosis after pandemic (H1N1) 2009Emerg Infect Dis201016697197320507748
   PubMed Web of Science ®Google Scholar
• van der VriesEIpDKCowlingBJOutcomes and susceptibility to neuraminidase inhibitors in individuals infected with different influenza B lineages: the influenza resistance information studyJ Infect Dis2016213218319026160744
   PubMed Web of Science ®Google Scholar
• Crum-CianfloneNFBacterial, fungal, parasitic, and viral myositisClin Microbiol Rev200821347349418625683
   PubMed Web of Science ®Google Scholar
• BurnhamAJBaranovichTGovorkovaEANeuraminidase inhibitors for influenza B virus infection: efficacy and resistanceAntiviral Res2013100252053424013000
   PubMed Web of Science ®Google Scholar
• WongKKJainSBlantonLDharaRBrammerLFryAMFinelliLInfluenza-associated pediatric deaths in the United States, 2004–2012Pediatrics2013132579680424167165
   PubMed Web of Science ®Google Scholar
• HuJJKaoCLLeePIClinical features of influenza A and B in children and association with myositisJ Microbiol Immunol Infect2004372959815181490
   PubMedGoogle Scholar
• ShamCOTseKReview of children diagnosed with acute myositis of calves admitted to a regional hospital in Hong Kong in the period 2003–2012HK J Paediatr (new series)201520145150
   Web of Science ®Google Scholar
• TaremiM1AmorosoANaceHLGilliamBLInfluenza B-induced refractory cardiogenic shock: a case reportBMC Infect Dis20131345224079537
   PubMed Web of Science ®Google Scholar
• ChangHLHsuJFTsaiYMLinSYKuoHFYangCJAcute respiratory distress syndrome and acute myocarditis developed in a previously healthy adult with influenza BBMC Pulm Med201616126728359
   PubMed Web of Science ®Google Scholar
• TorresPAHelmstetterJAKayeAMKayeADRhabdomyolysis: pathogenesis, diagnosis, and treatmentOchsner J2015151586925829882
   PubMed Web of Science ®Google Scholar
• NaderiASPalmerBFRhabdomyolysis and acute renal failure associated with influenza virus type B infectionAm J Med Sci20063322888916909056
   PubMed Web of Science ®Google Scholar
• HungPLLinPCTsengPLInfluenza-B associated rhabdomyolysis and acute renal failureIndian Pediatr201350659559623942401
   PubMed Web of Science ®Google Scholar
• CiarambinoTAdinolfiLEGiordanoMAcute rhabdomyolysis in healthy womanAm J Emerg Med2016341113
   Web of Science ®Google Scholar
• MizuguchiMInfluenza encephalopathy and related neuropsychiatric syndromesInfluenza Other Respir Viruses20137Suppl 3677124215384
   PubMed Web of Science ®Google Scholar
• StudahlMInfluenza virus and CNS manifestationsJ Clin Virol200328322523214522059
   PubMed Web of Science ®Google Scholar
• AkÖBitekerFCagYInfluenza B-associated encephalopathy in two adultsJ Infect Chemother201218696196422526386
   PubMed Web of Science ®Google Scholar
• FioreAEFryAShayDGubarevaLBreseeJSUyekiTMCenters for Disease Control and Prevention (CDC)Antiviral agents for the treatment and chemoprophylaxis of influenza recommendations of the Advisory Committee on Immunization Practices (ACIP)MMWR Recomm Rep2011601124
   PubMedGoogle Scholar
• McKimm-BreschkinJLInfluenza neuraminidase inhibitors: antiviral action and mechanisms of resistanceInfluenza Other Respir Viruses20137Suppl 1253623279894
   PubMed Web of Science ®Google Scholar
• McKimm-BreschkinJTrivediTHampsonANeuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivirAntimicrob Agents Chemother20034772264227212821478
   PubMed Web of Science ®Google Scholar
• FlanneryAHThompson BastinMLOseltamivir dosing in critically ill patients with severe influenzaAnn Pharmacother20144881011101824816209
   PubMed Web of Science ®Google Scholar
• IpDKLauLLChanKHThe dynamic relationship between clinical symptomatology and viral shedding in naturally acquired seasonal and pandemic influenza virus infectionsClin Infect Dis201662443143726518469
   PubMed Web of Science ®Google Scholar
• LiTCChanMCLeeNClinical implications of antiviral resistance in influenzaViruses2015794929494426389935
   PubMed Web of Science ®Google Scholar
• HeGMassarellaJWardPClinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802Clin Pharmacokinet199937647148410628898
   PubMed Web of Science ®Google Scholar
• Abdel-GhafarANChotpitayasunondhTGaoZWriting Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) VirusUpdate on avian influenza A (H5N1) virus infection in humansN Engl J Med2008358326127318199865
   PubMed Web of Science ®Google Scholar
• KarschKChenXMieraOPharmacokinetics of oral and intravenous oseltamivir treatment of severe influenza B virus infection requiring organ replacement therapyEur J Drug Metab Pharmacokinet2016 Epub ahead of print
   PubMed Web of Science ®Google Scholar
• HuiDSLeeNAdjunctive therapies and immunomodulating agents for severe influenzaInfluenza Other Respir Viruses20137Suppl 35259
   PubMed Web of Science ®Google Scholar
• ReddyKPBajwaEKParkerRAOnderdonkABWalenskyRPRelationship between upper respiratory tract influenza test result and clinical outcomes among critically ill influenza patientsOpen Forum Infect Dis20163113
   Web of Science ®Google Scholar
• Dong Won ParkDWYhiJYFatal clinical course of probable invasive pulmonary aspergillosis with influenza B infection in an immunocompetent patientTuberc Respir Dis2014773141144
   Google Scholar
• HasejimaNYamatoKTakezamaSKobayashiHKadoyamaCInvasive pulmonary aspergillosis associated with influenza BRespirology200510111611915691249
   PubMed Web of Science ®Google Scholar
• TacconeFSVan den AbeeleAMBulpaPAspICU Study InvestigatorsEpidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomesCrit Care201519725928694
   PubMed Web of Science ®Google Scholar
• PietschUMüller-HöckerCEnzler-TschudyAFilipovicMSevere ARDS in a critically ill influenza patient with invasive pulmonary aspergillosisIntensive Care Med201642101632163327177530
   PubMed Web of Science ®Google Scholar
• WautersJBaarIMeerssemanPInvasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective studyIntensive Care Med20123891117611768
   Web of Science ®Google Scholar
• StevensDAMelikianGLAspergillosis in the “nonimmunocompromised” hostImmunol Invest2011407–875176621985304
   PubMed Web of Science ®Google Scholar
• AlshabaniK1HaqAMiyakawaRPallaMSoubaniAOInvasive pulmonary aspergillosis in patients with influenza infection: report of two cases and systematic review of the literatureExpert Rev Respir Med201591899625547335
   PubMed Web of Science ®Google Scholar